Abstract:Although animal studies concerning cytokines or stem cell therapies have shown hope for arteriogenesis, clinical results have been disappointing due to multi-factoral causes. Monocyte signaling is a dominant and important mediator of arteriogenesis activity and monocyte-signaling pathways can be severely impaired during various cardiovascular disorders. Hydrogen sulfide (H2S) is produced by cystathionine-γ lyase (CSE), and a potential gaseous molecule that has many positive cytoprotective effects including regulation of monocyte functions. However, a molecular mechanism of CSE/H2S regulation of arteriogenesis during ischemia is not established. Therefore, we hypothesized that CSE/H2S modulates arterial collateral formation in mouse hind limb ischemia via IL-16/bFGF dependent pathway. Unilateral permanent hind limb ischemia was induced in wild type (WT) and CSE−/− mice. Mice were then randomly assigned into four groups (8 mice, each group); WT PBS, WT DATS (a hydrogen sulfide donor, 200μg/kg, twice daily, IV until day 21), CSE- PBS, CSE−/− DATS. CSE activity and H2S levels in monocytes and tissues were determined in ischemic conditions and with inflammatory agents and studied both in vitro and in vivo. Tissue perfusion was determined using laser Doppler perfusion imaging system and the number and diameter of arterial collaterals measured using SPY angiography. Mature vessel density and monocyte recruitment was investigated by α-SMA/CD31/DAPI and MAC-2/DAPI positive staining. ELISA was used to measure IL-16 and bFGF levels. CSE activity and free H2S levels were increased during ischemia and TNF- α stimulation in cultured monocytes. CSE activity and H2S levels were also elevated in bone marrow derived and circulating monocytes, and tissues after ischemia induction in WT mice but not from CSE−/− mice. Blood perfusion, blush rate, number and diameter of collaterals, and mature vessel density were decreased in CSE−/− mice compared to WT mice that was rescued by DATS therapy. IL-16 levels were reduced in ischemic tissue of CSE−/− mice compared to WT mice. IL-16 levels were restored by DATS treatment in ischemic tissue of CSE- mice. Monocyte recruitment was significantly reduced in ischemic tissues of CSE−/− mice that were rescued by DATS treatment. Lastly bFGF levels were less in ischemic tissue of CSE−/− mice compared to WT mice and that were restored by DATS therapy. CSE/H2S regulates arteriogenesis via IL-16 mediated monocyte recruitment and up-regulation of bFGF levels in ischemic tissue of CSE−/− mice. These findings reveal a novel role of monocyte dependent CSE/H2S in regulating arteriogenesis activity.

YB-1 Recruits Drosha to Promote Splicing of Pri-Mir-192 to Mediate the Proangiogenic Effects of H2S

YB-1 Recruits Drosha to Promote Splicing of pri-miR-192 to Mediate the Proangiogenic Effects of H 2 S

Hydrogen Sulfide Promotes Angiogenesis by Downregulating Mir-640 Via the VEGFR2/mTOR Pathway.

Hydrogen Sulfide Improves Angiogenesis by Regulating the Transcription of pri-miR-126 in Diabetic Endothelial Cells

Hydrogen sulfide promotes angiogenesis 1 by down-regulating miR-640 2 via the VEGFR 2 / mTOR pathway 3 4

OP29 Identification of the Molecular Switch and the Receptor for H2S to Promote Angiogenesis

Hydrogen Sulfide Exerted a Pro-Angiogenic Role by Promoting the Phosphorylation of VEGFR2 at Tyr797 and Ser799 Sites in Hypoxia–Reoxygenation Injury

H2S Regulates Endothelial Nitric Oxide Synthase Protein Stability by Promoting Microrna-455-3p Expression.

Novel angiogenic activity and molecular mechanisms of ZYZ-803, a slow releasing hydrogen sulfide-nitric oxide hybrid molecule.

Hypoxia-inducible factor-1α is involved in the pro-angiogenic effect of hydrogen sulfide under hypoxic stress.

The Novel Proangiogenic Effect of Hydrogen Sulfide is Dependent on Akt Phosphorylation.

Role of hydrogen sulphide in physiological and pathological angiogenesis

The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia.

Mirna-30 Family Inhibition Protects Against Cardiac Ischemic Injury by Regulating Cystathionine-Γ-lyase Expression.

Mechanisms of Angiogenesis: Role of Hydrogen Sulphide

Hydrogen Sulfide Rescues High Glucose-Induced Migration Dysfunction in HUVECs by Upregulating Mir-126-3p.

P06 CSE/H2S Rescues Impaired Arteriogenesis in Mouse Hind Limb Ischemia Via IL-16 Dependant Monocyte Recruitment and Expression of Bfgf

Role of hydrogen sulfide-microRNA crosstalk in health and disease

The activation of the HIF-1α-VEGFA-Notch1 signaling pathway by Hydroxysafflor yellow A promotes angiogenesis and reduces myocardial ischemia-reperfusion injury

H2S is a Promoter of Angiogenesis: Identification of H2S "receptors" and Its Molecular Switches in Vascular Endothelial Cells.

P13 S-Propargyl-Cysteine (SPRC) promoted angiogenesis under both normal and ischemic conditions: Possible STAT3-mediated mechanism